Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer
- PMID: 34873480
- PMCID: PMC8640796
Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer
Abstract
Colorectal cancer (CRC) is one of the most heritable cancers, and genetic factors play an important role in the increased CRC risk. However, the well-established CRC-risk genes were limited for explaining the increased risk of CRC individuals. Germline mutations in DNA damage repair (DDR) genes have also been reported to be implicated in CRC heritability. Here, we aimed to determine the prevalence and significance of germline DDR and well-established CRC-risk gene variants in CRCs with paired somatic analyses. Next-generation sequencing (NGS) was performed on tumor tissues and paired white blood cells collected from 2160 Chinese patients with CRC using well-designed 381- or 733-cancer gene panel. Germline/somatic variations were identified and assessed for pathogenicity and likely pathogenicity. Of 2160 CRCs, 136 pathogenic germline mutations in 133 patients (133/2160, 6.1%) were identified in 21 genes, including 19 out of 32 examined DDR genes. Compared with non-carriers, individuals with germline variants were prone to a higher level of microsatellite instability (MSI) and tumor mutational burden (TMB), and an earlier age of onset. Somatic sequencing identified second hits in 24/133 (18%) patients with germline variants. Among the mismatch repair (MMR) genes with germline mutations, the second hit significantly increased MSI and TMB, particularly apparent in MSH6. All MMR germline variation carriers further with a second hit were all MSI-H and had an extraordinarily high level of TMB. Collectively, approximately 6.1% of CRC patients carried pathogenic germline variants, and additional somatic second hit increases the genomic instability in CRC, whereas the more clinical significance warrants further study.
Keywords: Colorectal cancer; DNA damage repair; germline mutation; somatic second hit.
AJCR Copyright © 2021.
Conflict of interest statement
Bei Zhang, Shuang Tong, Jinping Cai, Feilong Zhao, Xiaochen Zhao, and Shiqing Chen are employed by 3D Medicines Inc.
Figures



Similar articles
-
Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study.Front Oncol. 2019 Jun 26;9:550. doi: 10.3389/fonc.2019.00550. eCollection 2019. Front Oncol. 2019. PMID: 31297337 Free PMC article.
-
Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer.Front Genet. 2022 Jan 27;12:755629. doi: 10.3389/fgene.2021.755629. eCollection 2021. Front Genet. 2022. PMID: 35154239 Free PMC article.
-
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.Gut. 2018 Mar;67(3):447-455. doi: 10.1136/gutjnl-2016-312608. Epub 2016 Nov 8. Gut. 2018. PMID: 29439113
-
Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.Adv Biomed Res. 2018 Feb 16;7:28. doi: 10.4103/abr.abr_185_16. eCollection 2018. Adv Biomed Res. 2018. PMID: 29531926 Free PMC article. Review.
-
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.World J Gastroenterol. 2015 Aug 21;21(31):9253-61. doi: 10.3748/wjg.v21.i31.9253. World J Gastroenterol. 2015. PMID: 26309352 Free PMC article. Review.
Cited by
-
Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study.J Med Genet. 2023 Aug;60(8):760-768. doi: 10.1136/jmg-2022-108816. Epub 2023 Jan 10. J Med Genet. 2023. PMID: 36627197 Free PMC article.
-
Concurrent loss of MLH1, PMS2 and MSH6 immunoexpression in digestive system cancers indicating a widespread dysregulation in DNA repair processes.Front Oncol. 2022 Oct 26;12:1019798. doi: 10.3389/fonc.2022.1019798. eCollection 2022. Front Oncol. 2022. PMID: 36387226 Free PMC article.
-
Molecular characterization of Chinese patients with small bowel adenocarcinoma.Clin Transl Oncol. 2024 Sep;26(9):2205-2216. doi: 10.1007/s12094-024-03441-4. Epub 2024 Mar 21. Clin Transl Oncol. 2024. PMID: 38512449
-
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.BMC Cancer. 2024 Jun 1;24(1):668. doi: 10.1186/s12885-024-12454-9. BMC Cancer. 2024. PMID: 38824512 Free PMC article.
-
Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas.Ann Surg Oncol. 2025 May;32(5):3568-3577. doi: 10.1245/s10434-024-16621-x. Epub 2024 Dec 10. Ann Surg Oncol. 2025. PMID: 39656390
References
-
- Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–164. - PubMed
-
- Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85. - PubMed
-
- Lorans M, Dow E, Macrae FA, Winship IM, Buchanan DD. Update on hereditary colorectal cancer: improving the clinical utility of multigene panel testing. Clin Colorectal Cancer. 2018;17:e293–e305. - PubMed
-
- Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ American Society of Clinical Oncology; European Society of Clinical Oncology. Hereditary colorectal cancer syndromes: American society of clinical oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European society for medical oncology clinical practice guidelines. J. Clin. Oncol. 2015;33:209–217. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous